Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Davalintide (AC2307) in Obese or Overweight Subjects
NCT00785408Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2008
- Primary completion
- Sep 2009
- Countries
- 1
01
Overview
A Phase 2 trial of davalintide in obesity, sponsored by AstraZeneca. Started Dec 2008; status: completed.
02
Drugs
davalintide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00785408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00785408.